Factors contributing to the development of perceived stigma in people with newly diagnosed epilepsy: A one-year

Gha-Hyun Lee1, Sang-Ahm Lee2, Soon-Kee No3

  • 1Department of Neurology, University of Ulsan College of Medicine, Seoul, Republic of Korea; Department of Neurology, Pusan National University School of Medicine, Pusan, Republic of Korea.

Epilepsy & Behavior : E&B
|November 27, 2015
PubMed

Insights

Perceived stigma decreased in newly diagnosed people with epilepsy (PWE) over one year. Introverted personality, anxiety, and lower economic status were associated with higher stigma.

Area of Science:

  • Neurology
  • Psychiatry
  • Social Science

Background:

  • Epilepsy diagnosis can lead to significant perceived stigma.
  • Understanding the trajectory and predictors of stigma is crucial for intervention.

Purpose of the Study:

  • To evaluate the changes in perceived stigma over the first year in newly diagnosed people with epilepsy (PWE).
  • To identify demographic, clinical, and psychological factors associated with perceived stigma.

Main Methods:

  • A cohort of 218 newly diagnosed PWE from 12 Korean tertiary hospitals was recruited.
  • Perceived stigma was assessed using the Stigma Scale at baseline and one-year follow-up.
  • Logistic regression analyses identified predictive factors for perceived stigma.

Main Results:

  • Stigmatized feelings decreased from 30.7% at diagnosis to 17.6% at one year.
  • Introverted personality and high anxiety predicted stigma at diagnosis.
  • Introverted personality and lower economic status predicted stigma at one year.

Conclusions:

  • Introverted personality consistently predicted perceived stigma.
  • Anxiety and lower economic status were also significant factors related to stigma.
  • A reduction in perceived stigma is possible within the first year post-diagnosis.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.2K
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
848
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
956
Schizophrenia01:17

Schizophrenia

Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those...
1.6K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.2K